Stay updated on Nivolumab in Resectable Osteosarcoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Resectable Osteosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Resectable Osteosarcoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Sponsor branding/navigation items linking to the Moffitt center and its trial resources were removed from the page header/footer, reducing quick access to sponsor-related resources.
    Difference
    0.1%
    Check dated 2026-05-29T06:09:39.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 on the page, indicating a software patch with no changes to the study content.
    Difference
    0.0%
    Check dated 2026-05-14T23:00:44.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.2 to v3.5.3, reflecting a newer version of the ClinicalTrials.gov record.
    Difference
    0.0%
    Check dated 2026-04-30T17:18:42.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T11:04:52.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T20:20:19.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. No other visible changes to study details.
    Difference
    0.0%
    Check dated 2026-03-11T17:41:33.000Z thumbnail image

Stay in the know with updates to Nivolumab in Resectable Osteosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable Osteosarcoma Clinical Trial page.